The Enterprise Value as of December 2025 (TTM) for Adagio Therapeutics, Inc. (ADGI) is 225.64M

According to Adagio Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 225.64M. This represents a change of 435.22% compared to the average of 42.16M of the last 4 quarters.

Adagio Therapeutics, Inc. (ADGI) Historical Enterprise Value (quarterly & annually)

How has ADGI Enterprise Value performed in the past?

The mean historical Enterprise Value of Adagio Therapeutics, Inc. over the last ten years is 552.30M. The current 225.64M Enterprise Value has changed 3.99% with respect to the historical average. Over the past ten years (40 quarters), ADGI's Enterprise Value was at its highest in in the September 2021 quarter at 2.11B. The Enterprise Value was at its lowest in in the December 2021 quarter at -232793616.10.

Adagio Therapeutics, Inc. (ADGI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Adagio Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adagio Therapeutics, Inc. (ADGI) Average Enterprise Value

How has ADGI Enterprise Value performed in the past?

The current Enterprise Value of Adagio Therapeutics, Inc. (ADGI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adagio Therapeutics, Inc. (ADGI) Enterprise Value vs. Peers

How is ADGI’s Enterprise Value compared to its peers?

Adagio Therapeutics, Inc.’s Enterprise Value is less than Sage Therapeutics, Inc. (488.88M), less than iTeos Therapeutics, Inc. (245.99M), less than Opthea Limited (520.79M), greater than AzurRx BioPharma, Inc. (1.75M), less than Revance Therapeutics, Inc. (805.89M), greater than Concert Pharmaceuticals, Inc. (-126571000.00), greater than Claritas Pharmaceuticals, Inc. (923.66K), greater than Climb Bio, Inc. (184.83M), greater than Pardes Biosciences, Inc. (75.90M), greater than Oxurion N.V. (11.36M),

Build a custom stock screener for Adagio Therapeutics, Inc. (ADGI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adagio Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adagio Therapeutics, Inc. (ADGI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adagio Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.